A Case of Partially Reversible Oral-buccal-lingual Dyskinesia after Prolonged Levetiracetam Exposure

Vy Le,Kamalakar Surineni,Grant Elias

DOI: https://doi.org/10.1016/j.jagp.2024.01.190

2024-04-01

Abstract:Introduction Although antipsychotic drugs were previously believed to be the primary cause of tardive dyskinesia (TD), recent studies have challenged this belief, suggesting that other drug classes, including antiepileptic drugs such as levetiracetam, can also be linked to TD. This case report depicts partial resolution of oral-buccal-lingual dyskinesia upon discontinuation of levetiracetam. Methods n/a. Results An 86-year-old female with history of seizure disorder was admitted for evaluation of acute encephalopathy due to multiple etiologies, acute-on-chronic kidney injury, bleeding duodenal arteriovenous malformations, and community-acquired pneumonia. Patient started levetiracetam four years prior due to supratherapeutic phenytoin which was discontinued in the setting of choreoathetosis. She previously had akathisia months prior to the start of levetiracetam due to gabapentin withdrawal which resolved with restarting the medication. On hospital day 3, she developed acute onset choreoathetosis of the tongue that interrupted speech and feeding. Following cross-titration from levetiracetam to divalproex over the course of 21 days, there was global recovery from encephalopathy and ataxia, simultaneous with gradual improvement of her dyskinetic tongue movements, which resolved one week after completion of levetiracetam taper. Conclusions Our case highlights the potential implications of levetiracetam in dyskinetic movements, warranting close monitoring of patients taking this medication, particularly in older adults who may be more vulnerable to medication-related adverse effects, as well as consideration of alternative, better tolerated anticonvulsant therapies.

psychiatry,geriatrics & gerontology,gerontology